ONEVAX, LLC

Address

1928 SW 36TH PL
GAINESVILLE, FL, 32608-3436

Information

DUNS: 004095863
# of Employees: 1

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A novel biomaterial-based therapy utilizing auto-antigen and adjuvant for the amelioration of Type 1 Diabetes

    Amount: $238,328.00

    Immune mediated diseases such as type diabetes T D multiple sclerosis rheumatoid arthritis and systemic lupus erythematosis are reaching epidemic proportions in the US T D affects an estimated ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Biomaterial-based delivery of Interleukin-2 to Regulatory T Cells for the amelioration of Type 1 Diabetes

    Amount: $235,720.00

    Type Diabetes T D results from a breakdown of self tolerance that is characterized by immune cell mediated destruction of the insulin producing cells in the pancreas Ultimately glucose metabol ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  3. A novel biomaterial-based therapy to prevent type 1 diabetes

    Amount: $200,212.00

    DESCRIPTION (provided by applicant): Immune-mediated diseases such as type 1 diabetes (T1D), multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosis are reaching epidemic proportion ...

    SBIRPhase I2014Department of Health and Human Services
  4. Fast and Accurate Dynamic Simulations of Biological Systems

    Amount: $226,205.00

    DESCRIPTION (provided by applicant): Type 1 Diabetes (T1D) is thought to result from a breakdown of self-tolerance that is characterized by T cell-mediated destruction of the insulin-producing -cells ...

    SBIRPhase I2013Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government